Skip to content
Wednesday, August 26, 2026
Women's Health Trial Tracker — 2018
| Record | Record Date | Vuga Group | Change Status | Recency Days | Public Significance Score |
|---|
| Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies | 01/04/2018 | OBSERVATIONAL | unchanged | 3,156.85 | 0 |
|---|
| Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study) | 01/05/2018 | INTERVENTIONAL | unchanged | 3,155.85 | 0 |
|---|
| Study of IMNN-001 (Also Known as GEN-1) With NACT for Treatment of Ovarian Cancer (OVATION 2) | 01/09/2018 | INTERVENTIONAL | unchanged | 3,151.85 | 0 |
|---|
| Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes | 01/10/2018 | OBSERVATIONAL | unchanged | 3,150.85 | 0 |
|---|
| Gradient-Echo Spectroscopic Imaging Study of Saturated Fat and Breast Cancer | 01/17/2018 | INTERVENTIONAL | unchanged | 3,143.85 | 0 |
|---|
| Effects of Simvastatin on Uterine Leiomyoma Size | 01/17/2018 | INTERVENTIONAL | unchanged | 3,143.85 | 0 |
|---|
| Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome | 01/17/2018 | INTERVENTIONAL | unchanged | 3,143.85 | 0 |
|---|
| Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study) | 01/23/2018 | INTERVENTIONAL | unchanged | 3,137.85 | 0 |
|---|
| Mammography, Early Detection Biomarkers, Risk Assessment, and Imaging Technologies, MERIT Study | 01/24/2018 | OBSERVATIONAL | unchanged | 3,136.85 | 0 |
|---|
| Evaluation And Risk Assessment For Persistent Postsurgical Pain After Breast Surgery | 01/24/2018 | OBSERVATIONAL | unchanged | 3,136.85 | 0 |
|---|
| Perioperative Music Listening on Anxiety, Pain, Analgesia Use and Patient Satisfaction | 01/30/2018 | INTERVENTIONAL | unchanged | 3,130.85 | 0 |
|---|
| Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD | 01/31/2018 | INTERVENTIONAL | unchanged | 3,129.85 | 0 |
|---|
| Accelerated iTBS for Post Partum Depression | 01/31/2018 | INTERVENTIONAL | unchanged | 3,129.85 | 0 |
|---|
| Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy | 02/01/2018 | INTERVENTIONAL | unchanged | 3,128.85 | 0 |
|---|
| Study Looking at Biomarkers in Ovarian Cancer | 02/05/2018 | INTERVENTIONAL | unchanged | 3,124.85 | 0 |
|---|
| Study of Radiation Fractionation on Patient Outcomes After Breast REConstruction (FABREC) for Invasive Breast Carcinoma | 02/05/2018 | INTERVENTIONAL | unchanged | 3,124.85 | 0 |
|---|
| Exercise, Fitness and Tumor Profiling in Breast Cancer Patients | 02/07/2018 | OBSERVATIONAL | unchanged | 3,122.85 | 0 |
|---|
| Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer | 02/08/2018 | INTERVENTIONAL | unchanged | 3,121.85 | 0 |
|---|
| An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer | 02/12/2018 | INTERVENTIONAL | unchanged | 3,117.85 | 0 |
|---|
| Sweden Cancerome Analysis Network - Breast (SCAN-B) Coupled to Psychological Resilience | 02/13/2018 | OBSERVATIONAL | unchanged | 3,116.85 | 0 |
|---|
| Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma | 02/13/2018 | INTERVENTIONAL | unchanged | 3,116.85 | 0 |
|---|
| Identification of New Prognostic Markers for Breast Cancer. | 02/19/2018 | OBSERVATIONAL | unchanged | 3,110.85 | 0 |
|---|
| Accelerated Partial Breast Irradiation Study | 02/19/2018 | INTERVENTIONAL | unchanged | 3,110.85 | 0 |
|---|
| Endometrial Cancer Lymphadenectomy Trial | 02/19/2018 | INTERVENTIONAL | unchanged | 3,110.85 | 0 |
|---|
| Comprehensive Lifestyle Change To Prevent Breast Cancer | 02/27/2018 | INTERVENTIONAL | unchanged | 3,102.85 | 0 |
|---|
| The PREDICT Registry: | 02/28/2018 | OBSERVATIONAL | unchanged | 3,101.85 | 0 |
|---|
| Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients | 02/28/2018 | INTERVENTIONAL | unchanged | 3,101.85 | 0 |
|---|
| Older Breast Cancer Patients: Risk for Cognitive Decline | 03/01/2018 | OBSERVATIONAL | unchanged | 3,100.85 | 0 |
|---|
| Signal TrAnsduction Pathway Activity Analysis in OVarian cancER | 03/08/2018 | INTERVENTIONAL | unchanged | 3,093.85 | 0 |
|---|
| Omission of Radiation in Patients With Her-2 Positive Breast Cancer | 03/09/2018 | INTERVENTIONAL | unchanged | 3,092.85 | 0 |
|---|
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC | 03/13/2018 | INTERVENTIONAL | unchanged | 3,088.85 | 0 |
|---|
| Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors | 03/13/2018 | INTERVENTIONAL | unchanged | 3,088.85 | 0 |
|---|
| Individual Approach in Gynecological Cancer Brachytherapy | 03/15/2018 | INTERVENTIONAL | unchanged | 3,086.85 | 0 |
|---|
| PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer | 03/19/2018 | INTERVENTIONAL | unchanged | 3,082.85 | 0 |
|---|
| ASA in Prevention of Ovarian Cancer (STICs and STONEs) | 03/29/2018 | INTERVENTIONAL | unchanged | 3,072.85 | 0 |
|---|
| Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy | 04/03/2018 | INTERVENTIONAL | unchanged | 3,067.85 | 0 |
|---|
| Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer | 04/05/2018 | INTERVENTIONAL | unchanged | 3,065.85 | 0 |
|---|
| MRI Characterization of Mammographically Detected DCIS | 04/11/2018 | OBSERVATIONAL | unchanged | 3,059.85 | 0 |
|---|
| Autologous Ovarian Tissue Transplantation | 04/12/2018 | INTERVENTIONAL | unchanged | 3,058.85 | 0 |
|---|
| Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction | 04/25/2018 | OBSERVATIONAL | unchanged | 3,045.85 | 0 |
|---|
| LimPrOn: Limburg Pre-eclampsia Investigation | 04/26/2018 | INTERVENTIONAL | unchanged | 3,044.85 | 0 |
|---|
| Maternal Smoking Cessation and Pediatric Obesity Prevention | 05/02/2018 | INTERVENTIONAL | unchanged | 3,038.85 | 0 |
|---|
| Follow-up in Gynecological Cancer Survivors | 05/04/2018 | OBSERVATIONAL | unchanged | 3,036.85 | 0 |
|---|
| Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer | 05/08/2018 | INTERVENTIONAL | unchanged | 3,032.85 | 0 |
|---|
| A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy | 05/11/2018 | INTERVENTIONAL | unchanged | 3,029.85 | 0 |
|---|
| Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery | 05/14/2018 | INTERVENTIONAL | unchanged | 3,026.85 | 0 |
|---|
| RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy | 05/14/2018 | INTERVENTIONAL | unchanged | 3,026.85 | 0 |
|---|
| Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer | 05/16/2018 | INTERVENTIONAL | unchanged | 3,024.85 | 0 |
|---|
| Gestational Diabetes and Pharmacotherapy (GAP) | 05/17/2018 | INTERVENTIONAL | unchanged | 3,023.85 | 0 |
|---|
| Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma | 05/22/2018 | INTERVENTIONAL | unchanged | 3,018.85 | 0 |
|---|
| Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread | 05/23/2018 | INTERVENTIONAL | unchanged | 3,017.85 | 0 |
|---|
| Ultrasound Identification Automation Study | 05/24/2018 | OBSERVATIONAL | unchanged | 3,016.85 | 0 |
|---|
| IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry | 05/25/2018 | OBSERVATIONAL | unchanged | 3,015.85 | 0 |
|---|
| The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons | 05/29/2018 | OBSERVATIONAL | unchanged | 3,011.85 | 0 |
|---|
| Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer | 06/06/2018 | INTERVENTIONAL | unchanged | 3,003.85 | 0 |
|---|
| Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants | 06/06/2018 | INTERVENTIONAL | unchanged | 3,003.85 | 0 |
|---|
| Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort | 06/14/2018 | OBSERVATIONAL | unchanged | 2,995.85 | 0 |
|---|
| A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies | 06/15/2018 | INTERVENTIONAL | unchanged | 2,994.85 | 0 |
|---|
| Acupuncture and Integrative Care in Gynecological Surgery | 06/18/2018 | INTERVENTIONAL | unchanged | 2,991.85 | 0 |
|---|
| Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients | 06/18/2018 | INTERVENTIONAL | unchanged | 2,991.85 | 0 |
|---|
| A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients | 06/19/2018 | OBSERVATIONAL | unchanged | 2,990.85 | 0 |
|---|
| Birth Cohort Study of China Medical University | 06/19/2018 | OBSERVATIONAL | unchanged | 2,990.85 | 0 |
|---|
| GammaPod Registry and Quality of Life Nomogram | 06/19/2018 | OBSERVATIONAL | unchanged | 2,990.85 | 0 |
|---|
| Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers | 06/20/2018 | INTERVENTIONAL | unchanged | 2,989.85 | 0 |
|---|
| Gynecologic Extramammary Paget's Disease | 06/20/2018 | OBSERVATIONAL | unchanged | 2,989.85 | 0 |
|---|
| Vaginal Microbiome Exposure and Immune Responses in C-section Infants | 06/26/2018 | INTERVENTIONAL | unchanged | 2,983.85 | 0 |
|---|
| CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer | 06/26/2018 | INTERVENTIONAL | unchanged | 2,983.85 | 0 |
|---|
| Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging | 06/26/2018 | OBSERVATIONAL | unchanged | 2,983.85 | 0 |
|---|
| Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer | 06/27/2018 | INTERVENTIONAL | unchanged | 2,982.85 | 0 |
|---|
| Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job | 06/28/2018 | INTERVENTIONAL | unchanged | 2,981.85 | 0 |
|---|
| Chronic Effect of Fasting | 06/29/2018 | INTERVENTIONAL | unchanged | 2,980.85 | 0 |
|---|
| Breast Aesthetics by Three Dimensional Measures | 07/06/2018 | OBSERVATIONAL | unchanged | 2,973.85 | 0 |
|---|
| Study of the Safety and Effectiveness of Motiva Implants® | 07/09/2018 | INTERVENTIONAL | unchanged | 2,970.85 | 0 |
|---|
| Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod | 07/10/2018 | INTERVENTIONAL | unchanged | 2,969.85 | 0 |
|---|
| Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer | 07/11/2018 | INTERVENTIONAL | unchanged | 2,968.85 | 0 |
|---|
| The Effect of Membrane Sweeping on the Delivery Time and the Need of Induction in Term Pregnancy | 07/19/2018 | INTERVENTIONAL | unchanged | 2,960.85 | 0 |
|---|
| Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer | 07/19/2018 | INTERVENTIONAL | unchanged | 2,960.85 | 0 |
|---|
| Baby's First Years | 07/20/2018 | INTERVENTIONAL | unchanged | 2,959.85 | 0 |
|---|
| Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer | 07/23/2018 | INTERVENTIONAL | unchanged | 2,956.85 | 0 |
|---|
| Mineral Status in Pregnant Women | 07/26/2018 | OBSERVATIONAL | unchanged | 2,953.85 | 0 |
|---|
| A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer | 07/27/2018 | INTERVENTIONAL | unchanged | 2,952.85 | 0 |
|---|
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF | 07/27/2018 | INTERVENTIONAL | unchanged | 2,952.85 | 0 |
|---|
| Non-contrast DWI for Supplemental Screening | 07/31/2018 | OBSERVATIONAL | unchanged | 2,948.85 | 0 |
|---|
| A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes | 07/31/2018 | INTERVENTIONAL | unchanged | 2,948.85 | 0 |
|---|
| SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer | 08/03/2018 | INTERVENTIONAL | unchanged | 2,945.85 | 0 |
|---|
| Pessary Satisfaction Criteria for Urogenital Prolapse | 08/06/2018 | OBSERVATIONAL | unchanged | 2,942.85 | 0 |
|---|
| Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. | 08/06/2018 | INTERVENTIONAL | unchanged | 2,942.85 | 0 |
|---|
| Paclitaxel + Carboplatin + Durvalumab With or Without Oleclumab for Previously Untreated Locally Recurrent Inoperable or Metastatic TNBC | 08/06/2018 | INTERVENTIONAL | unchanged | 2,942.85 | 0 |
|---|
| Image Guided IMRT, Radiochemotherapy and MRI-based IGABT in Locally Advanced Cervical Cancer | 08/06/2018 | INTERVENTIONAL | unchanged | 2,942.85 | 0 |
|---|
| Assessment of Sensory Gating, Attention, and Executive Control in Breast Cancer | 08/07/2018 | OBSERVATIONAL | unchanged | 2,941.85 | 0 |
|---|
| Development of Advanced Double Intravenous Vasopressor Automated (ADIVA) System | 08/08/2018 | INTERVENTIONAL | unchanged | 2,940.85 | 0 |
|---|
| PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer | 08/09/2018 | OBSERVATIONAL | unchanged | 2,939.85 | 0 |
|---|
| Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization | 08/09/2018 | OBSERVATIONAL | unchanged | 2,939.85 | 0 |
|---|
| Comparative Antiresorptive Efficacy Discontinuation of Denosumab | 08/09/2018 | INTERVENTIONAL | unchanged | 2,939.85 | 0 |
|---|
| Evaluation of Clinical Impact of Interruption VS Maintenance of AI in Patients With Locally Advanced/ Metastatic Low Grade Endometrial Stromal Sarcoma (LGESS) | 08/10/2018 | INTERVENTIONAL | unchanged | 2,938.85 | 0 |
|---|
| CFI-400945 in Patients With Advanced/Metastatic Breast Cancer | 08/10/2018 | INTERVENTIONAL | unchanged | 2,938.85 | 0 |
|---|
| Analysis and Optimization of Predictive and Therapeutic Models in Uterine Neoplasms | 08/10/2018 | OBSERVATIONAL | unchanged | 2,938.85 | 0 |
|---|
| Study of the Physiology of Pre-eclampsia and Vascular IUGR With Constitution of a Biological Collection | 08/10/2018 | OBSERVATIONAL | unchanged | 2,938.85 | 0 |
|---|
| Maternal Outcomes Following Manual Lysis of the Placenta. | 08/13/2018 | INTERVENTIONAL | unchanged | 2,935.85 | 0 |
|---|
| Maternal Grandmothers in the Born in Guangzhou Cohort Study | 08/16/2018 | OBSERVATIONAL | unchanged | 2,932.85 | 0 |
|---|
| Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS | 08/16/2018 | INTERVENTIONAL | unchanged | 2,932.85 | 0 |
|---|
| MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer | 08/16/2018 | INTERVENTIONAL | unchanged | 2,932.85 | 0 |
|---|
| Multidisciplinary Treatment of Chronic Vulvar Pain | 08/21/2018 | INTERVENTIONAL | unchanged | 2,927.85 | 0 |
|---|
| Post-operative Emesis and Pain Outcomes After Cesarean Delivery | 08/24/2018 | OBSERVATIONAL | unchanged | 2,924.85 | 0 |
|---|
| Improving Sleep Quality During Pregnancy Using an Oral Appliance | 08/24/2018 | INTERVENTIONAL | unchanged | 2,924.85 | 0 |
|---|
| Partial Breast Versus no Irradiation for Women With Early Breast Cancer | 08/24/2018 | INTERVENTIONAL | unchanged | 2,924.85 | 0 |
|---|
| The LUCINDA Trial: LeUprolide Plus Cholinesterase Inhibition to Reduce Neurological Decline in Alzheimer's | 08/28/2018 | INTERVENTIONAL | unchanged | 2,920.85 | 0 |
|---|
| Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients | 08/29/2018 | INTERVENTIONAL | unchanged | 2,919.85 | 0 |
|---|
| Recurrent Ovarian CarcinoSarcoma Anti-pd-1 Niraparib | 08/29/2018 | INTERVENTIONAL | unchanged | 2,919.85 | 0 |
|---|
| Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone | 09/07/2018 | INTERVENTIONAL | unchanged | 2,910.85 | 0 |
|---|
| Investigating the Structured Use of Ultrasound Scanning for Fetal Growth | 09/07/2018 | OBSERVATIONAL | unchanged | 2,910.85 | 0 |
|---|
| Intravenous Estrogen in Kidney Transplant Study | 09/10/2018 | INTERVENTIONAL | unchanged | 2,907.85 | 0 |
|---|
| Postpartum Low-Dose Aspirin and Preeclampsia | 09/12/2018 | INTERVENTIONAL | unchanged | 2,905.85 | 0 |
|---|
| AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma | 09/12/2018 | INTERVENTIONAL | unchanged | 2,905.85 | 0 |
|---|
| A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients | 09/14/2018 | INTERVENTIONAL | unchanged | 2,903.85 | 0 |
|---|
| Laser Vaginal Treatment for SUI | 09/14/2018 | INTERVENTIONAL | unchanged | 2,903.85 | 0 |
|---|
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy | 09/14/2018 | INTERVENTIONAL | unchanged | 2,903.85 | 0 |
|---|
| My Personalized Breast Screening | 09/14/2018 | INTERVENTIONAL | unchanged | 2,903.85 | 0 |
|---|
| Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 | 09/17/2018 | INTERVENTIONAL | unchanged | 2,900.85 | 0 |
|---|
| Ribociclib and Letrozole Treatment in Ovarian Cancer | 09/17/2018 | INTERVENTIONAL | unchanged | 2,900.85 | 0 |
|---|
| Fetoscopic Endoluminal Tracheal Occlusion | 09/17/2018 | INTERVENTIONAL | unchanged | 2,900.85 | 0 |
|---|
| Evaluation of an Online, Remote Cognitive Battery for Use in Cancer Survivorship | 09/17/2018 | OBSERVATIONAL | unchanged | 2,900.85 | 0 |
|---|
| RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer | 09/18/2018 | INTERVENTIONAL | unchanged | 2,899.85 | 0 |
|---|
| Dietary Management of Gestational Diabetes | 09/21/2018 | INTERVENTIONAL | unchanged | 2,896.85 | 0 |
|---|
| Preoperative Virtual Reality to Reduce Pain on Gynaecologic Patients Undergoing Surgery | 09/26/2018 | INTERVENTIONAL | unchanged | 2,891.85 | 0 |
|---|
| An Ultrasound Guided Automated Spinal Landmark Identification System | 09/27/2018 | INTERVENTIONAL | unchanged | 2,890.85 | 0 |
|---|
| Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH) | 09/28/2018 | INTERVENTIONAL | unchanged | 2,889.85 | 0 |
|---|
| Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP | 10/02/2018 | OBSERVATIONAL | unchanged | 2,885.85 | 0 |
|---|
| mHealth Integrated Model of Hypertension, Diabetes and Antenatal Care in India and Nepal | 10/09/2018 | INTERVENTIONAL | unchanged | 2,878.85 | 0 |
|---|
| Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia | 10/11/2018 | INTERVENTIONAL | unchanged | 2,876.85 | 0 |
|---|
| Tocotrienols for Obesity of Postmenopausal Women | 10/15/2018 | INTERVENTIONAL | unchanged | 2,872.85 | 0 |
|---|
| A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors | 10/16/2018 | INTERVENTIONAL | unchanged | 2,871.85 | 0 |
|---|
| PAGETEX® Photodynamic Therapy Device for the Treatment of Extra Mammary Paget's Disease of the Vulva (EMPV). | 10/19/2018 | INTERVENTIONAL | unchanged | 2,868.85 | 0 |
|---|
| Robot-assisted Approach to Cervical Cancer | 10/25/2018 | INTERVENTIONAL | unchanged | 2,862.85 | 0 |
|---|
| Exploring Respiratory Health Outcomes From Sustained Use of Efficient Cookstoves | 11/01/2018 | INTERVENTIONAL | unchanged | 2,855.85 | 0 |
|---|
| A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer | 11/02/2018 | INTERVENTIONAL | unchanged | 2,854.85 | 0 |
|---|
| Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation Therapy | 11/05/2018 | INTERVENTIONAL | unchanged | 2,851.85 | 0 |
|---|
| Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment | 11/06/2018 | INTERVENTIONAL | unchanged | 2,850.85 | 0 |
|---|
| Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer | 11/06/2018 | INTERVENTIONAL | unchanged | 2,850.85 | 0 |
|---|
| Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer | 11/07/2018 | INTERVENTIONAL | unchanged | 2,849.85 | 0 |
|---|
| Peer Approaches to Lupus Self-management | 11/07/2018 | INTERVENTIONAL | unchanged | 2,849.85 | 0 |
|---|
| Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer | 11/08/2018 | INTERVENTIONAL | unchanged | 2,848.85 | 0 |
|---|
| Durvalumab Treatment in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib Treatment in Advanced Ovarian Cancer Patients | 11/09/2018 | INTERVENTIONAL | unchanged | 2,847.85 | 0 |
|---|
| An mHealth Intervention to Improve Outcomes for Women With HIV/AIDS | 11/13/2018 | INTERVENTIONAL | unchanged | 2,843.85 | 0 |
|---|
| The Role of Estrogen in the Neurobiology of Eating Disorders | 11/14/2018 | INTERVENTIONAL | unchanged | 2,842.85 | 0 |
|---|
| A Study of Novel Anti-cancer Agents in Patients With Metastatic Triple Negative Breast Cancer | 11/15/2018 | INTERVENTIONAL | unchanged | 2,841.85 | 0 |
|---|
| Cardiovascular Disease Risk in Women With Endometriosis | 11/19/2018 | INTERVENTIONAL | unchanged | 2,837.85 | 0 |
|---|
| Exercise to Prevent AnthraCycline-based Cardio-Toxicity Study 2.0 (EXACT2) | 11/21/2018 | INTERVENTIONAL | unchanged | 2,835.85 | 0 |
|---|
| 3D Animation and Models to Aid Management of Fetal CDH | 11/23/2018 | OBSERVATIONAL | unchanged | 2,833.85 | 0 |
|---|
| Validation Study on RENEW's Aingeal at KK Women's and Children's Hospital | 11/23/2018 | INTERVENTIONAL | unchanged | 2,833.85 | 0 |
|---|
| Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance | 11/28/2018 | OBSERVATIONAL | unchanged | 2,828.85 | 0 |
|---|
| Collection of Donated Placenta for Isolation of Mitochondria for Research and for Future Use in Mitochondrial Augmentation Therapies | 12/03/2018 | OBSERVATIONAL | unchanged | 2,823.85 | 0 |
|---|
| AMBULAPSE STUDY Feasibility Study on Laparoscopic Double-mesh Sacrocolpopexy With or Without Robotic Assistance, in Female Patients Presenting With Symptomatic Pelvic Organ Prolapse, Based on an Outpatient Treatment Model. | 12/05/2018 | INTERVENTIONAL | unchanged | 2,821.85 | 0 |
|---|
| Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making | 12/05/2018 | INTERVENTIONAL | unchanged | 2,821.85 | 0 |
|---|
| LAparoscopic Preventive PRErectal Mesh | 12/05/2018 | INTERVENTIONAL | unchanged | 2,821.85 | 0 |
|---|
| Short Term Aspirin on the Biologic and Immunologic Changes of the Fallopian Tube | 12/11/2018 | INTERVENTIONAL | unchanged | 2,815.85 | 0 |
|---|
| Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) | 12/11/2018 | INTERVENTIONAL | unchanged | 2,815.85 | 0 |
|---|
| Post Operative Cognitive Dysfunction After Breast Surgery | 12/13/2018 | OBSERVATIONAL | unchanged | 2,813.85 | 0 |
|---|
| Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise | 12/14/2018 | OBSERVATIONAL | unchanged | 2,812.85 | 0 |
|---|
| Exploring the Potential of Novel Biomarkers Based on Plasma microRNAs for a Better Management of Pelvic Gynecologic Tumors | 12/17/2018 | INTERVENTIONAL | unchanged | 2,809.85 | 0 |
|---|
| Metabolic and Bone Changes After Adjuvant Cancer Treatments in Early Non-metastatic Breast Cancer | 12/24/2018 | OBSERVATIONAL | unchanged | 2,802.85 | 0 |
|---|
| Vaginal Cuff Brachytherapy Fractionation Study | 12/24/2018 | INTERVENTIONAL | unchanged | 2,802.85 | 0 |
|---|
| Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule | 12/24/2018 | INTERVENTIONAL | unchanged | 2,802.85 | 0 |
|---|
| Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer | 12/26/2018 | INTERVENTIONAL | unchanged | 2,800.85 | 0 |
|---|
| One Week Versus Three Week in Adjuvant Radiotherapy in Breast Cancer | 12/27/2018 | INTERVENTIONAL | unchanged | 2,799.85 | 0 |
|---|